Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
Top Stories
NEW Special Report on the Guangdong-Hong Kong-Macao…
In 2013, Chinese President Xi Jinping launched the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative, corralling the two Special Administrative…
Veterinary pharma: The weakest link in countering AMR
As deputy director of health and nutrition at the European Commission EC, Martin Seychell has a lot on his plate if…
The pharmacy of the future
Meghann Chilcott, Senior Vice President of OrderInsite, discusses the changing role of pharmacists and technicians.…
China: a new biopharma model emerging
Professor Richard Barker, founder of New Medicine Partners reflects on China’s very different approach to…
Rehumanising the Health System
Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems…
Flouting IP to deliver cheap Hep C drugs
With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect…
